FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

788332000: Product containing only polatuzumab vedotin in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3779944019 Polatuzumab vedotin only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779945018 Product containing only polatuzumab vedotin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779944019 Polatuzumab vedotin only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779945018 Product containing only polatuzumab vedotin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Polatuzumab vedotin only product in parenteral dose form Plays role Antineoplastic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Polatuzumab vedotin only product in parenteral dose form Is a Polatuzumab vedotin only product true Inferred relationship Existential restriction modifier (core metadata concept)
Polatuzumab vedotin only product in parenteral dose form Is a Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Polatuzumab vedotin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polatuzumab vedotin true Inferred relationship Existential restriction modifier (core metadata concept) 1
Polatuzumab vedotin only product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Polatuzumab vedotin only product in parenteral dose form Count of base of active ingredient un false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start